Marengo CIMS Hospital continues to redefine cardiac excellence with over 80 successful transcatheter valve procedures, marking a significant milestone in structural heart care in Gujarat. With 69 TAVI (Transcatheter Aortic Valve Implantation), 10 TMVR (Transcatheter Mitral Valve Replacement), and 1 TTVR (Transcatheter Tricuspid Valve Replacement), the hospital stands at the forefront of minimally invasive cardiac innovations, delivering safer outcomes for high-risk patients.
Transcatheter valve therapies have transformed the landscape of cardiac treatment, especially for patients who are not ideal candidates for open-heart surgery. At Marengo CIMS, these advanced procedures are performed with precision, reducing recovery time, minimizing complications, and improving overall quality of life. The hospital’s integrated cardiac team ensures that each patient receives personalized, evidence-based care backed by cutting-edge technology.
A landmark achievement includes performing TAVI in a high-risk dialysis patient with just 20% cardiac function, demonstrating clinical expertise in managing critically complex cases. Such success reflects the hospital’s commitment to pushing clinical boundaries while maintaining the highest standards of patient safety and outcomes.
Adding to its legacy, Marengo CIMS Hospital has successfully performed Gujarat’s first non-surgical TTVR, setting a new benchmark in tricuspid valve care. This breakthrough highlights the institution’s leadership in adopting next-generation cardiac interventions and its dedication to bringing global best practices to regional healthcare.
Since pioneering TAVI and TMVR procedures in Gujarat in 2015, Marengo CIMS Hospital has remained a trusted destination for advanced cardiac care. With a focus on innovation, compassion, and clinical excellence, the hospital continues to shape the future of heart health, offering hope and healing to patients across the region and beyond.